An innovative cardiac ablation system for treating cardiac arrhythmias
Argá Medtech is developing the next generation non-thermal cardiac ablation system By developing next generation pulsed field ablation and irreversible electroporation technologies, their unique power generator offers unmatched flexibility when used with its proprietary catheter.
CEO David Neale
Advent Contact Shahzad Malik
Advent are founding investors of Argá Medtech and co-led their Series A in 2021.
Private Companies
Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise
Press Release. Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise - Funding will advance US and EU clinical studies of innovative pulsed field…
Read More
Argá Medtech Shows Promise for New Cardiac Ablation Technology at 2022 Heart Rhythm Society Annual Meeting
Press Release. Argá Medtech’s next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillation Preliminary feasibility study results demonstrate the company’s Coherent…
Read More
